MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202411023758 A) filed by Council Of Scientific And Industrial Research, New Delhi, on March 26, 2024, for 'indole based small molecule antivirals against sars-cov-2.'
Inventor(s) include Arindam Talukdar; Israful Hoque; Binita Patra; Nirmal Das; Krishan Gopal Thakur; Rajesh Ringe; Nittu Singh; Akshay Joshi; and Ravneet Singh Chawla.
The application for the patent was published on Oct. 31, under issue no. 44/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to the preparation of indole-based compounds in free form or an acceptable salt form potential therapeutic target as an antiviral agent against SARS-Cov2. The indole-based small molecules are, capable of antiviral activityin RT-qPCR and cell-based assay in SARS-CoV-2 infected VERO E6 cells, that may ultimately be used to achieve improved human health in patients against covid-19 or other similar viral diseases."
Disclaimer: Curated by HT Syndication.
